The safety and tolerability of GLP-1 receptor agonists in the treatment of type 2 diabetes: a review-Reference-Cited by-同舟云学术

The safety and tolerability of GLP-1 receptor agonists in the treatment of type 2 diabetes: a review

Published:2011-09 Issue:6 Volume:27 Page:528-542
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metab. Res. Rev.

Author:

Aroda Vanita R.,Ratner Robert

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference96 articles.

1. Eli Lilly and Company, Amylin Pharmaceuticals Inc 2005 http://www.prnewswirecom/cgi-bin/micro_storiespl?ACCT = 916306&TICK = LLY&STORY = /www/story/06-09-2005/0003828751&EDATE = Jun + 9,+ 2005

2. Merck C̈o., Inc 2006 http://www.merck com/newsroom/press_releases/finan-cial/2006_1212 html

3. Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus;Richter;Cochrane Database Syst Rev,2008

4. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes;Drucker;Lancet,2006

5. Effect of porcine gastric inhibitory polypeptide on beta-cell function in type I and type II diabetes mellitus;Krarup;Metabolism,1987

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From diabetes to diverse domains: the multifaceted roles of GLP-1 receptor agonists;Molecular Biology Reports;2024-07-23

2. Dilemmas in Elderly Diabetes and Clinical Practice Involving Traditional Chinese Medicine;Pharmaceuticals;2024-07-16

3. The interplay of glucose-dependent insulinotropic polypeptide in adipose tissue;Journal of Endocrinology;2024-04-03

4. Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes: an update;Expert Opinion on Drug Metabolism & Toxicology;2024-04-02

5. Role of SGLT2 Inhibitors, DPP-4 Inhibitors, and Metformin in Pancreatic Cancer Prevention;Cancers;2024-03-28